2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Brain Neoplasms
12
Cognitive Dysfunction
4
Radiation Injuries
3
Neoplasms
3
Multiple Myeloma
3
Glioma
3
Breast Neoplasms
3
Lymphoma, B-Cell
2
Lymphoma
2
Glioblastoma
2
Fatigue
2
Colorectal Neoplasms
2
Astrocytoma
2
Triple Negative Breast Neoplasms
1
Stroke
1
Sarcoma
1
Prostatic Neoplasms
1
Pituitary Neoplasms
1
Parkinson Disease
1
Osteosarcoma
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neurofibromatosis 1
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Interventions
Paclitaxel
8
Oxaliplatin
6
Carboplatin
5
Vincristine
4
Radiotherapy
4
Mental Status and Dementia Tests
4
Leucovorin
4
Amifostine
4
Taxes
3
Sodium Chloride
3
Procarbazine
3
Methotrexate
3
Magnetic Resonance Spectroscopy
3
Fluorouracil
3
Cytarabine
3
Cyclophosphamide
3
Cisplatin
3
xaliproden
2
glucarpidase
2
Surveys and Questionnaires
2
Rituximab
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy, Conformal
2
Psychiatric Rehabilitation
2
Prednisolone
2
Magnesium Sulfate
2
Folfox protocol
2
Duloxetine Hydrochloride
2
Doxorubicin
2
Dexamethasone
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neurotoxicity Syndromes
×
Neuropsychological Tests
×
Clear all
NCT05510596
2024-08-09
MR-ICANS
University Hospital, Montpellier
Phase NA
Completed
25 enrolled